SCYX
SCYX
NASDAQ · Pharmaceuticals

Scynexis Inc

$0.89
-0.01 (-0.73%)
As of Mar 25, 5:10 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +808.9% upside
Low Target $6.66
Average Target $8.12
High Target $12.47
Current Price $0.89
Current
$0.89
Target
$8.12
$6.66 $8.12 avg $12.47
Scenario Analysis
Bear Case
$6.66
645.5%
Low target
Base Case
$8.12
+808.9%
Avg target
Bull Case
$12.47
+1,295.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$1.31
-31.8% from high
52-Week Low
$0.57
+58.1% from low
Target vs 52W High
$8.12
+519.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%